Table 2 Logistic analysis of relationship between mRSS and qualitative evaluation of organ involvement
| Â | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
N | OR (95% CI) | N | OR (95% CI) | |
Death | 177 | 1.15* (1.03 to 1.29) | 176 | 1.23* (1.03 to 1.46) |
Lung involvement | ||||
 Interstitial lung disease | 175 | 1.04* (1.00 to 1.08) | 174 | 1.05* (1.01 to 1.09) |
 Restrictive impairment | 176 | 1.07** (1.03 to 1.12) | 175 | 1.07** (1.02 to 1.12) |
 Diffusion impairment | 171 | 1.07** (1.02 to 1.11) | 170 | 1.06* (1.01 to 1.11) |
Heart involvement | ||||
 Diastolic dysfunction | 136 | 1.03 (0.96 to 1.10) |  |  |
 Pulmonary hypertension | 177 | 0.97 (0.86 to 1.09) |  |  |
 Heart failure | 177 | 1.11 (0.99 to 1.23) |  |  |
Renal involvement | ||||
 SRC | 177 | 1.11* (1.02 to 1.20) | 176 | 1.11* (1.01 to 1.23) |
Gastrointestinal involvement | ||||
 Reflux esophagitis | 161 | 1.03 (0.99 to 1.07) |  |  |
 Ileus | 177 | 1.04 (0.95 to 1.13) |  |  |
Musculoskeletal involvement | ||||
 Myositis | 177 | 1.03 (0.95 to 1.11) |  |  |